[{"id":"a0ae763d-fd7e-4a3a-8b7f-b5e9a545ee4c","acronym":"ABIGENE","url":"https://clinicaltrials.gov/study/NCT01858441","created_at":"2021-01-18T08:18:24.935Z","updated_at":"2024-07-02T16:36:37.840Z","phase":"","brief_title":"Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate","source_id_and_acronym":"NCT01858441 - ABIGENE","lead_sponsor":"Centre Antoine Lacassagne","biomarkers":" CYP17A1 • SLCO2B1","pipe":"","alterations":" ","tags":["CYP17A1 • SLCO2B1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e abiraterone acetate"],"overall_status":"Completed","enrollment":" Enrollment 148","initiation":"Initiation: 04/01/2013","start_date":" 04/01/2013","primary_txt":" Primary completion: 09/06/2020","primary_completion_date":" 09/06/2020","study_txt":" Completion: 12/03/2020","study_completion_date":" 12/03/2020","last_update_posted":"2020-12-04"}]